SIROLIMUS
Generic: SIROLIMUS
Camber PharmaceuticalsManufacturer
ORALRoute
SIROLIMUSActive Substance
2024-09-16Original Approval
SIROLIMUS is FDA application ANDA215080, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2024-05-01
Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08Failed Impurities/Degradation Specifications
Class III2021-05-12
Sirolimus Tablets 1 mg, 30 Tablets (5 blister cards x 6 unit doses), Rx only, Packaged and Distributed by: American HealFailed Impurities/Degradation Specifications
Class III2022-05-03
Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 MaFailed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the s
Class III2016-06-03
Sirolimus Tablets, 1 mg, 100-count bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Visakhapatnam - 5Failed impurities/degradation: out of specification result for impurity secorapamycin.
Top Reported Reactions
1
OFF LABEL USE
2,076 reports
2
DRUG INEFFECTIVE
1,139 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
786 reports
4
PYREXIA
531 reports
5
DIARRHOEA
529 reports
6
PNEUMONIA
500 reports
7
DRUG INTERACTION
450 reports
8
ACUTE KIDNEY INJURY
443 reports
9
THROMBOTIC MICROANGIOPATHY
386 reports
10
TRANSPLANT REJECTION
384 reports